Study on Effect of Filgrastim in Severe Leukopenia Condition in Dogs
Koppula Anusha, Basiri Dinesh, Keshamoni Ramesh, Jupaka Shashank, K. Mohanambal
Abstract
Koppula Anusha, Basiri Dinesh, Keshamoni Ramesh, Jupaka Shashank, K. Mohanambal
Abstract
Filgrastim is a recombinant Methionyl Human Granulocyte- Stimulating Factor (r-metHuGCSF) analog used to stimulate the proliferation and differentiation of granulocytes in humans. Young pups and kittens suffer from severe leukopenia and neutropenia condition (etiology may be viral or bacterial or parasitic). Neutrophils being first line of defense in immunity system and decreased count may lead to increased mortality. In the present investigation 3 dogs with severe leukopenia and neutropenia condition when treated dogs with Filgrastim @ 10 μg/ kg b.wt. s.c daily for three days along with other supportive treatment, was found to be effective in correcting the hematological parameters within 48 hours of last dose of treatment and all those showed fast recovery also.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Filgrastim is a recombinant Methionyl Human Granulocyte- Stimulating Factor (r-metHuGCSF) analog used to stimulate the proliferation and differentiation of granulocytes in humans. Young pups and kittens suffer from severe leukopenia and neutropenia condition (etiology may be viral or bacterial or parasitic). Neutrophils being first line of defense in immunity system and decreased count may lead to increased mortality. In the present investigation 3 dogs with severe leukopenia and neutropenia condition when treated dogs with Filgrastim @ 10 μg/ kg b.wt. s.c daily for three days along with other supportive treatment, was found to be effective in correcting the hematological parameters within 48 hours of last dose of treatment and all those showed fast recovery also.
Key concepts: Leukopenia, Filgrastim, Neutropenia, Medicine, Granulocyte, Granulocyte colony-stimulating factor, Immunology, Internal medicine